Cargando…
Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: A population-based study
BACKGROUND: The Endocrine Society Clinical Practice Guidelines recommend the avoidance of medications that may cause weight gain (i.e., obesogenic medications) in individuals with overweight or obesity. Obesity disproportionately affects people with lower socioeconomic status (SES); however, it is u...
Autores principales: | Lyu, Beini, Chang, Alex R., Inker, Lesley A., Selvin, Elizabeth, Grams, Morgan E., Shin, Jung-Im |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348594/ https://www.ncbi.nlm.nih.gov/pubmed/35928911 http://dx.doi.org/10.1016/j.lana.2022.100249 |
Ejemplares similares
-
Weight changes following antidiabetic mediation use: Real‐world evidence from health system data
por: Lyu, Beini, et al.
Publicado: (2022) -
Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S.
por: Tsai, Ching-Wei, et al.
Publicado: (2014) -
Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022) -
Obesogens: An Environmental Link to Obesity
por: Holtcamp, Wendee
Publicado: (2012) -
Role of Obesogens in the Pathogenesis of Obesity
por: Shahnazaryan, Urszula, et al.
Publicado: (2019)